Media OutReach Newswire Launches Industry-First Press Release Distribution Campaign Intelligence Report

HONG KONG SAR – Media OutReach – 25 July 2023 – Media OutReach Newswire, Asia’s first global newswire, has launched the next-generation SaaS integrated communications portal that offers three simple steps in press release submission, centralised post-release reports and a groundbreaking Press Release Distribution Campaign Intelligence Report that provides holistic insights of press release distribution […]

Media OutReach Newswire Launches Industry-First Press Release Distribution Campaign Intelligence Report Read More

‫إيفيد وأيه ستار يفتتحان مختبرًا مشتركًا بالتعاون متعدد المؤسسات عبر الحدود بقيمة 10 ملايين دولار سنغافوري لتعزيز الذكاء الاصطناعي للسكان والصحة الرقمية

سنغافورة- Media OutReach – 25 يوليو 2023 – أنشأت إيفيد تكنولوجي ووكالة العلوم والتكنولوجيا والبحوث ((أيه*ستار)) مختبرًا مشتركًا للنهوض بأبحاث الذكاء الاصطناعي من أجل صحة السكان والصحة الرقمية [1]، لتعزيز حلول الرعاية الصحية وإحداث تأثير إيجابي على المرضى.أقيم حفل توقيع لترشيح مختبر إيفيد وأيه ستار المشترك في سنغافورة للتأكيد على الالتزام بتطوير حلول الذكاء الاصطناعي […]

‫إيفيد وأيه ستار يفتتحان مختبرًا مشتركًا بالتعاون متعدد المؤسسات عبر الحدود بقيمة 10 ملايين دولار سنغافوري لتعزيز الذكاء الاصطناعي للسكان والصحة الرقمية Read More

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Seagate Technology Holdings plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – STX

NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of Seagate Technology Holdings plc (NASDAQ: STX) between September 15, 2020 and October 25, 2022, both dates inclusive (the “Class Period”), of the important September 8, 2023 lead plaintiff deadline. SO […]

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Seagate Technology Holdings plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – STX Read More

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Proterra Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PTRA

NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Proterra Inc. (NASDAQ: PTRA) between August 2, 2022 and March 15, 2023, both dates inclusive (the “Class Period”), of the important September 12, 2023 lead plaintiff deadline. SO WHAT: If you purchased […]

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Proterra Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PTRA Read More

ROSEN, A TOP RANKED LAW FIRM, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – DHR

NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Danaher Corporation (NYSE: DHR) between April 21, 2022 and April 24, 2023, both dates inclusive (the “Class Period”), of the important September 15, 2023 lead plaintiff deadline. SO WHAT: If you purchased […]

ROSEN, A TOP RANKED LAW FIRM, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – DHR Read More

EB5 Capital’s Riverfront at the Navy Yard (JF8) Project Receives First I-829 Approval

WASHINGTON, July 24, 2023 (GLOBE NEWSWIRE) — EB5 Capital is pleased to announce that it has received notice from the United States Citizenship and Immigration Services (USCIS) regarding the first I-829 petition approval associated with an investor in the firm’s Riverfront at the Navy Yard (JF8) project. The I-829 approval marks a significant achievement for […]

EB5 Capital’s Riverfront at the Navy Yard (JF8) Project Receives First I-829 Approval Read More

APLS INVESTOR NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – APLS

NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) resulting from allegations that Apellis may have issued materially misleading business information to the investing public. SO WHAT: If […]

APLS INVESTOR NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – APLS Read More